UB596
ProductTobramycin Sulfate for Injection
Strength80mg
IndicationsNeonatal sepsis; Central nervous system infection; Meningitis; Genitourinary tract infection; Lower respiratory tract infection; Biliary tract infection; Intra-abdominal infection; Peritonitis; Osteomyelitis; Burn; Skin infection; Soft tissue infection; Otitis media; Sinusitis; Encephalitis; Ventriculitis
TherapeuticsInfectious Diseases; Neurology; Respiratory; Otolaryngology; Gastroenterology & Hepatology; Nephrology & Urology; Dermatology
GMPCN - NMPA
RegistrationChina
ModalitiesSmall Molecule
Exclusive Summary
- Tobramycin Sulfate for Injection is a WHO essential medicine and guideline-recommended drug, possessing clear global clinical demand and market foundation.
- Original patents have expired, presenting significant generic opportunities in a highly competitive yet large market.
- Chinese manufacturing's cost advantage combined with potential international certifications makes it highly price competitive in the global generic market.
- Its injectable formulation holds irreplaceable clinical value in specific infections and severe treatment, securing its market position.
- In certain emerging markets, generic versions have substantial substitution potential due to the high cost of originator drugs.
How can we help you?
Receive insights into the latest events and regulatory updates
Sent directly to your email
Get industry insights and Unibest news here
Contact Us →